A prospective study of the efficacy of routine decontamination for gastrointestinal endoscopes

合集下载

9篇新英格兰英文摘要(考试要考)

9篇新英格兰英文摘要(考试要考)

1.绝经后骨质疏松症妇女中Strontium Ranelate对椎体骨折的影响The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis背景骨质疏松性结构破坏和骨质脆弱是骨质形成减少而骨质吸收增加的结果。

在一项2期临床试验中,strontium ranelate,一种通过增加骨质形成和减少骨质吸收来解除骨质重塑的口服活性药物,已经显示可降低椎体骨折危险而增加骨矿密度。

方法为了在一项3期临床试验中评估strontium ranelate对预防椎体骨折的疗效,我们将1649例患有骨质疏松症(低骨矿密度)并至少有一个椎体骨折的绝经后妇女随机分成两组,使她们分别接受每天2g口服strontium ranelate 或安慰剂治疗共3年。

我们在研究前和研究期间给两组病人都补充钙质和维生素D。

每年1次进行椎体X线检查,每6个月1次进行骨矿密度测定。

结果 Strontium ranelate组比安慰剂组较少病人发生新的椎体骨折,骨折发生危险下降在治疗的第1年中为49%,在3年研究期间为41%(相对危险为0.59,95%可信区间为0.48~0.73)。

Strontium ranelate使36个月时的腰椎骨矿密度增加14.4%,股骨颈骨矿密度增加8.3%(两项比较均P<0.001)。

两组之间的严重不良事件发生率没有显著差异。

结论采用strontium ranelate治疗绝经后骨质疏松症可使椎体骨折危险早期出现持久下降。

(N Engl J Med 2004;350:459-68.January 29,2004)王华译The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women withPostmenopausal OsteoporosisABSTRACTBackground Osteoporotic structural damage and bone fragility result from reduced bone formation and increased bone resorption.In a phase 2 clinical trial, strontium ranelate, an orally active drug that dissociates bone remodeling by increasing bone formation and decreasing bone resorption, has been shown to reduce the risk of vertebral fractures and to increase bone mineral density.Methods To evaluate the efficacy of strontium ranelate in preventing vertebral fractures in a phase 3 trial, we randomly assigned1649 postmenopausal women with osteoporosis (low bone mineral density) and at least one vertebral fracture to receive 2 g of oral strontium ranelate per day or placebo for three years.We gave calcium and vitamin D supplements to both groups before and during the study. Vertebral radiographs were obtained annually,and measurements of bone mineral density were performed every six months.Results New vertebral fractures occurred in fewer patients in the strontium ranelate group than in the placebo group, with a risk reduction of 49 percent in the first year of treatment and 41 percent during the three-year study period (relative risk, 0.59; 95 percent confidence interval, 0.48 to 0.73). Strontium ranelate increased bone mineral density at month 36 by 14.4percent at the lumbar spine and 8.3 percent at the femoral neck(P<0.001 for both comparisons). There were no significant differences between the groups in the incidence of serious adverse events.Conclusions Treatment of postmenopausal osteoporosis with strontium ranelate leads to early and sustained reductions in the risk of vertebral fractures.2.渗出性缩窄性心包炎Effusive-constrictive PericarditisJaume Sagristà-Sauleda,M.D.,等西班牙巴塞罗那Valld'Hebron大学总医院心脏科,等背景渗出性缩窄性心包炎是一种罕见心包综合征,其特征为伴有由紧张性心包渗出引起的心脏填塞和由脏层心包引起的缩窄。

PD术后并发症

PD术后并发症
?国外报道4050?国内报道325手术并发症的概念国内在应用外科手术治疗某一种原发病的过程中由于手术创伤的打击机体抵抗疾病能力减退机体特异质或解剖变异或手术操作失误或其他由手术带来的身体综合因素改变使机体遭受新的损害
胰十二指肠切除术 手术并发症及有关问题
四川大学· 华西医院· 肝胆胰外科
张肇达 严律南 刘续宝 曾勇 陈晓理 胡伟明 麦刚 彭兵 陈哲宇 吴鸿 李振军 张懿 乐新会
• Pancreas. 2007 Oct;35(3):273-5. Links
– The clinical results of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy in consecutive 55 cases. – Hayashibe A, Kameyama M. – Department of Surgery, Bell Land General Hospital, Osaka, Japan. akirah1@ – OBJECTIVES: Pancreatic anastomotic leakage remains a major troublesome complication after pancreaticoduodenectomy. Thus, various technical modifications regarding the pancreatic anastomosis after pancreaticoduodenectomy have been attempted to minimize anastomotic leakage. We have performed duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa (layer-to-layer pancreaticojejunostomy) and obtained extremely favorable results. METHODS: During 1999 to 2006, 55 patients (27 women and 28 men) underwent duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa after pancreaticoduodenectomy. The mean age was 64.6 years (range, 33-84 years). RESULTS: Median postoperative hospital stay was 32.8 days. Morbidity rate due to early postoperative complication was 9.1%, with no pancreatic anastomotic leakage. CONCLUSIONS: There was low complication rate and no pancreatic anastomotic leakage in consecutive 55 patients who underwent pancreaticoduodenectomy. We consider that duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa is extremely safe, reliable, and favorable for the anastomosis after pancreaticoduodenectomy.

阿奇霉素分散片联合盐酸多西环素片治疗非淋菌性宫颈炎的疗效对比

阿奇霉素分散片联合盐酸多西环素片治疗非淋菌性宫颈炎的疗效对比

医药科研阿奇霉素分散片联合盐酸多西环素片治疗非淋菌性宫颈炎的疗效对比李常科 (广州南粤医院 药剂科,广东广州 511406)摘要:目的:探究阿奇霉素分散片联合盐酸多西环素片治疗非淋菌性宫颈炎的疗效。

方法:选取我院收治的非淋菌性宫颈炎患者84例为观察对象,根据治疗方案不同分为参照组和研究组各42例。

参照组进行盐酸多西环素片治疗,研究组进行阿奇霉素分散片联合盐酸多西环素片治疗。

对比两组疗效、安全性、疾病症状消失时间以及对炎症介质指标水平的影响。

结果:研究组治疗总有效率高于参照组,下腹坠胀、阴道分泌物、泌尿系统感染等疾病症状消失时间均短于参照组(P<0.05);治疗后,研究组TNF-α、CRP、IL-6、PCT等炎症介质水平均低于参照组(P<0.05);两组患者治疗期间不良反应发生率比较无明显差异(P>0.05)。

结论:阿奇霉素分散片联合盐酸多西环素片治疗非淋菌性宫颈炎可提升疗效,促疾病症状消失,并改善患者炎症介质指标水平。

关键词:非淋菌性宫颈炎;阿奇霉素分散片;盐酸多西环素片;疗效非淋菌性宫颈炎作为常见妇科疾病,有易复发、难根治的特点,且发病后严重影响患者日常生活、危及患者生命健康。

临床救治多采用盐酸多西环素片,有明显疗效及抗菌效果,但因近年人们对其耐药性增强,致使单用盐酸多西环素片的治疗效果有限。

阿奇霉素分散片对阻断各类病原体转肽、抑制感染等有明显效果,应用于非淋菌性宫颈炎救治中亦有积极意义[1~3]。

本研究旨在探究阿奇霉素分散片联合盐酸多西环素片治疗非淋菌性宫颈炎的疗效。

1资料和方法1.1 基线资料选取我院2021年1~10月收治的非淋菌性宫颈炎患者84例为观察对象,根据治疗方案不同分为参照组和研究组各42例。

参照组:年龄23~48岁,平均(30.12±2.96)岁;病程1~3年,平均(1.65±0.21)年;支原体感染15例,衣原体感染17例,混合感染10例。

研究组:年龄22~49岁,平均(30.43±2.54)岁;病程1~3年,平均(1.72±0.25)年;支原体感染14例,衣原体感染19例,混合感染患者9例。

新的第二代非镇静抗组胺药依巴斯汀

新的第二代非镇静抗组胺药依巴斯汀

with cefepime as empiric therapy for fever and neutropenia.A m J Med ,1993,95(Suppl 4A )∶S4816 Saez 2Llorens X ,Castano E ,G arcia R ,et al .Prospective ran 2domized comparison of cefepime and cefotaxime for treat 2ment of bacterial meningitis in infants and children.A nti mi 2crob A gents Chemother ,1995,39(4)∶93717 Schwartz R ,Y oung L RD ,Ramirez 2Ronda C ,et al .Intrave 2nenous cefepime versus intravenous ceftazidime for the treat 2ment of serious skin and skin structure infections.A m JMed ,1993,95(Suppl 4A )∶S5518 Shafiri R ,G eckler R ,Childs S.A comparative study of ce 2fepime versus ceftazidime in the treatment of urinary tract in 2fections.A m J Med ,1993,95(Suppl 4A )∶S5519 Tauber M G ,Hackbarth C J ,Scott KG ,et al .New cephalos 2porins cefotaxime ,cefepimizole ,BM Y28142,and HR810in experimental pneumococcal meningitis in rabbits.A nti mi 2crob A gents Chemother ,1985,27(3)∶34020 Tsai YH ,Bies M ,Leitner F ,et al .Therapeutic studies ofcefepime (BM Y 28142)in murine meningitis and pharma 2cokinetics in neonatal rats.A nti microb A gents Chemother ,1990,34(5)∶733(收稿:1997—01—29 修回:1997—12—01)新的第二代非镇静抗组胺药依巴斯汀虞瑞尧(解放军总医院皮肤科,北京100853)摘要 目的:介绍新的第二代非镇静抗组胺药依巴斯汀。

植物药治疗前列腺增生症的研究进展

植物药治疗前列腺增生症的研究进展
“u J等【’51对灵芝醇B的药理作进行了研究,认为灵芝
展【J1.中国现代实用医学杂志,2006,5(5):41--42. 【6】6朱威,胡福良,李英华,等.花粉治疗前列腺增生的研究进 展【J】.蜜蜂杂志,2005,28(12):8—10. 【7】吴岩印,赵筱萍,李兵.前列康治疗前列腺增生的研究进 展【J】.中国社区医师,2007,23(1):44—44. 【8】杜海利,郑州达,陈森期,等.舍尼通治疗良性前列腺增生 的临床观察【J1.齐齐啥尔医学院学报,2009,30(8):243—244. 【91
文献标识码:A
文章编号:1673—9043(2010)02一0111-02
良性前列腺增生(BPH)是前列腺的尿道周围细胞的良 性腺瘤性增生,是老年男性的常见病、多发病。60—69岁年龄 段老人中重度BPH患病率为50%~60%,70~80岁年龄段的 患病率则高达80%~90%1”。植物药已经逐渐成为治疗BPH 的热点,占据了整个BPH治疗药物市场的30%一50%[2-∞。现 就近年来国内外有关植物药治疗前列腺增生的临床及实验 研究综述如下。 1舍尼通(cernilton) 舍尼通为黑麦属花粉经100%破壳后提取物,是通过微 生物的酵解作用而制成的。其有效成分为水溶性物质阿魏酰 1一丁二胺(P5)和脂溶性植物生长素(EAl0),P5与EAl0可 以抑制环氧合酶和脂合酶活性,阻止白i烯和PGEI的合成。 药理实验证实,舍尼通水提物能抑制幼年大鼠前列腺生 长,并使包皮腺和精囊有萎缩的倾向,还能有效阻滞双氢睾 酮(DHT)与受体结合,从而阻止DHT诱发的腺体组织增生, 促使腺体缩:j,14j。研究认为舍尼通可以明显抑制前列腺上皮 细胞和成纤维细胞的增殖,且上皮细胞的反应更为敏感,可 有效控制激素敏感细胞的异常生长151。

无托槽隐形矫治器的临床应用及疗效评价

无托槽隐形矫治器的临床应用及疗效评价

口腔医学2020年12月第40卷第12期• 1143 •无托槽隐形矫治器的临床应用及疗效评价吴珊珊,田密,周珊,刘杰,王晓峰[摘要]无托槽隐形矫治器(clear aligner,CA)在如今的正畸领域势不可挡,凭借其美观与舒适的独特优势,贏得医生与患者的一致好评。

但是,无托槽隐形矫治器仍有其不足之处,也有很多方面不如传统的固定矫治器。

该文主要对隐形矫治器多方面的表达效率进行综述,以为临床医生提供设计指导,_[关键词]无托槽;隐形矫治器;表达效率[中图分类号]R783.5 [文献标识码] A [文章编号]1003-9872(2020)12-1143-04[doi] 10.13591/ki.kqyx.2020.12.017Clinical application and efficacy evaluation of dear alignerWU Shanshan, TIAN Mi, ZHOU Shan , LIU Jie, WANG Xiaofeng. ( Department o f Stomatology, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000,China)Abstract :Clear aligner ( CA) is an irresistible device in the field of orthodontics, and has won the praise of doctors and patients for its unique advantages of beauty and comfort. However, clear aligner still has its shortcomings and is not as good as the traditional fixed oral appliance in many aspects. This paper reviews the expression efficiency of clear aligner from many aspects, thus providing design guide for clinical doctors.Key words:non-supporting groove;invisible corrector;expression efficiencyStomatology, 2020,40 ( 12 ): 1143 -1146随着无托槽隐形矫治技术的进步,其矫治适应 证也日益广泛。

法洛四联症根治术的围手术期麻醉管理

法洛四联症根治术的围手术期麻醉管理
(二 )辅助 检查 1. 超 声心 动 图诊 断和 多普 勒血 流诊 断 :术 前超 声检查 可 以明确诊 断 法洛 四联 症 ,并确 定 室 间 隔缺 损 的位 置 和 特 点 ,但 对 于 肌 部 小 室 间 隔 缺 损 ,由于 左 右心 室压 力 相 近 不 易诊 断。 左 右 心 室 的 大 小 ,右 心 室流 出道 狭 窄 程 度 以及 主 肺 动 脉 及 分 支 起 始 部 的发 育 情况 ,均 可 以得到 详 细 的评 估 。 2.造 影 :大部 分 患儿 通过 超声 检查 可 以明确诊 断和获 得 相 关 病 理 解 剖 和 病 理 生 理 信 息 。对 于 远 端 较小 室 间隔缺 损 和 远 端 肺 血 管 发 育 及 冠 状 动脉 走行 ,需要血 管 造 影诊 断。 对 于 伴 有 大 的体 肺 侧 支 血管 ,术 前进 行 封 堵 ,将 会 降低 术 后 死 亡 率 和 心 肺 并发 症发 生率 。 二 、术 中管理 (一 )麻 醉 管理 麻 醉用 药需根 据 患 儿 的不 同病理 生理 特 点 ,选 择适 宜 的药物 。对 于 室 间隔 缺 损 较 大 ,右 心 室 流 出 道梗 阻不 明显 的非 发 绀 患 儿 ,麻 醉 用 药 上 要避 免 降 低肺 血 管 阻力和 增 加体 循 环 阻 力 ,尽 量 减少 液体 输 入 。 而对于 重度 发 绀 患 儿 ,则 应 该 给 予 足 够 的 液体 输入 ,避 免使 用 降低体 循 环血 管 阻力 的 药物 。 对 于术前 缺 氧发 作 频 繁 的 患儿 ,在 没 有 开放 的 外周 静脉 ,以 七 氟 烷 吸入 麻 醉 诱 导 为 佳 ;肌 内注 射 氯胺 酮麻 醉 可 能 会 增 加 缺 氧 发 作 的 危 险。体 外 循 环 开始 前 ,麻 醉维持 使 用 芬太 尼 等 阿 片 类 药用 量 应 该 相对 较 大。矫 治术 芬 太 尼 总 量 20—50 g/kg,咪 唑安定 总量 200—500 g/kg,吸入 七 氟 烷 或 异 氟 烷 辅 助麻 醉 。肌松 药可 以选 择 哌 库 溴铵 、维 库 溴 铵和 阿 曲库 铵等 。

医学文献指标的中英文术语对照

医学文献指标的中英文术语对照

医学文献指标的中英文术语对照引言:医学文献是医学研究和临床实践中不可或缺的重要信息来源。

在阅读和理解医学文献时,掌握准确的中英文术语对照是十分必要的。

本文将介绍一些常见的医学文献指标的中英文术语对照,帮助读者更好地理解和应用这些指标。

一、Study Design (研究设计)1. 随机对照试验 (Randomized Controlled Trial, RCT)- 定义:将研究对象随机分为实验组和对照组,对比两组结果以评估干预措施的疗效- 示例: A randomized controlled trial of drug A on patients with hypertension2. 前瞻性队列研究 (Prospective Cohort Study)- 定义:在研究开始之前,根据暴露因素进行观察,随访研究对象并记录结果- 示例: A prospective cohort study of smoking and lung cancer risk3. 横断面研究 (Cross-sectional Study)- 定义:在某个特定时间点上收集数据,不考虑因果关系- 示例: A cross-sectional study of the prevalence of diabetes in a rural community二、Outcome Measures (研究终点指标)1. 死亡率 (Mortality Rate)- 定义:在一定时间内发生死亡的患者数与特定人群总数之比- 示例: The mortality rate of patients with heart failure after one year of follow-up2. 生存率 (Survival Rate)- 定义:在一定时间内生存下来的患者数与特定人群总数之比- 示例: The 5-year survival rate of breast cancer patients receiving chemotherapy3. 病情进展率 (Progression Rate)- 定义:患者疾病进展的速度或患病程度的评估指标- 示例: The progression rate of multiple sclerosis measured by MRI scans三、Statistical Analysis (统计分析)1. 方差分析 (Analysis of Variance, ANOVA)- 定义:用于比较多个组别差异的统计方法- 示例: One-way ANOVA was used to analyze the differences in blood pressure among different age groups2. 相关分析 (Correlation Analysis)- 定义:评估两个变量之间关系的统计方法- 示例: Pearson correlation analysis was performed to examine the association between BMI and blood glucose levels3. 生存分析 (Survival Analysis)- 定义:评估患者生存时间的统计方法,常用于研究肿瘤等疾病- 示例: Kaplan-Meier survival analysis was used to assess the overall survival rates of lung cancer patients四、Evidence Levels (证据级别)1. 临床实证 (Level of Evidence)- 定义:根据研究设计和方法的科学性和可靠性评估研究证据的质量- 示例: This meta-analysis provides high-level evidence for the efficacy of drug B in treating depression2. 系统综述及Meta分析 (Systematic Review and Meta-analysis)- 定义:对多个独立研究进行整体分析和结论汇总的研究方法- 示例: A systematic review and meta-analysis of the effectiveness of acupuncture for chronic pain management3. 专家共识 (Expert Consensus)- 定义:基于专家意见和经验形成的共识性陈述- 示例: The current guidelines are based on expert consensus and clinical experience结论:通过掌握医学文献指标中的中英文术语对照,读者能够更准确地理解和应用这些指标,在医学研究和临床实践中获得准确和可靠的信息支持。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

A prospective study of the efficacyof routine decontamination for gastrointestinal endoscopes andthe risk factors for failureLinda Bisset,MSmed,a Yvonne E.Cossart,MBBS,DCP,FRCP,a Warwick Selby,MBBS,FRACP,MD,b Richard West, MBBS,FRCS,b Denise Catterson,RN,b Kate O’Hara,BMedSci(Hons),a and Karen Vickery,BVSc,MVSc,PhD a Sydney,New South Wales,AustraliaBackground:Patient-ready endoscopes were monitored over an80-week period to determine the efficacy of decontamination procedures in a busy endoscopy center.Decontamination failure was related to patient and procedural parameters.Methods:Samples from patient-ready endoscopes were cultured aerobically and anaerobically and subjected to polymerase chain reaction(PCR)to detect hepatitis B virus(HBV),hepatitis C virus(HCV),and HIV.PCR to detect coliforms from109culture negative washes was used as a surrogate marker for biofilm in endoscopes.PCR was used to detect the presence of Helicobactor pylori in endoscopes used on infected patients.Procedural information such as biopsy retrieval,endoscope number,diagnosis,attending personnel,and decontamination system procedures was collected.Results:Gastroscopes(n51376)and colonoscopes(n5987)were equally contaminated(1.8%vs1.9%,respectively)with low numbers of organisms commonly isolated from the nasopharynx and/or feces.Only1wash contained viral nucleic acid(HCV).There was a significant correlation(P,.001)between the number of times a patient-ready endoscope was contaminated and its frequency of use.Colonoscopes used on patients with gastrointestinal disease were significantly more likely to remain contam-inated through the decontamination process(P,.05).All other patient,staff,and decontamination system parameters remained not statistically significant.Coliform DNA was detected in40%of culture-negative washes collected from patient-ready endo-scopes,suggesting the presence of biofilm.No H pylori DNA was detected.Conclusion:Recommended decontamination procedures do not entirely eliminate persistence of low numbers of organisms on a few endoscopes,but this is unlikely to cause serious consequences in patients.Bacterial biofilm is difficult to remove and may explain this low-level persistence.(Am J Infect Control2006;34:274-80.)The risk of infection in patients undergoing surgical procedures has been progressively reduced by imple-mentation of increasingly stringent infection control policies.Endoscopy presents special problems because endoscopes cannot be steam sterilized,and surgical manipulation such as biopsy may provide tissue access for gutflora or bloodborne viruses.Endoscopy is an important tool for monitoring extremely ill patients,many of whom are immunocompromised and thus at increased risk from introduced pathogens.These pa-tients are also likely to harbor high loads of bacteria and viruses,which may lead to high-level contamina-tion on instruments.There are many case reports of bacterial infection after endoscopy,some of which report transmission of pathogenic organisms from patient to patient.1-3 Spach et al3reviewed scientific articles published between1966and1992,finding281episodes of nos-ocomial transmission of pathogens attributable to endoscopy.Since then,most published endoscopy-related nosocomial transmissions have been related to a lapse in endoscope-reprocessing protocols or gen-eral infection control practices such as reuse of syringes and have resulted in hepatitis C virus(HCV) being transmitted.4An increase in risk of pathogen transmission has been related to unacceptable clean-ing and disinfection,5,6failure to sterilize accessory equipment,7incorrect germicide use,8improper dry-ing,9or defective equipment.10Current infection control guidelines for endoscope reprocessing published by various organizations11-13 have been developed from general principles.ThereFrom the Department of Infectious Diseases and Immunology and The Australian Centre for Hepatitis Virology,The University of Sydney,a and Page5Endoscopy Suite,Royal Prince Alfred Hospital,b Sydney,NSW, Australia.Reprint requests:Karen Vickery,BVSc,MVSc,PhD,Department of Infectious Diseases and Immunology,Blackburn Building D06,Univer-sity of Sydney,Sydney,NSW,Australia2006.E-mail:kvickery@infdis. .au.Supported by NHMRC grant number9937934and a NHMRC Industry Fellowship(to K.V.).0196-6553/$32.00Copyrightª2006by the Association for Professionals in Infection Control and Epidemiology,Inc.doi:10.1016/j.ajic.2005.08.007274have been few direct attempts to assess the efficacy of these regimes,to validate recommendations about lab-oratory monitoring of decontamination procedures,or to pinpoint the factors leading to failure.The current study evaluated the survival of bacteria on endoscopes after routine cleaning and decontami-nation.This was related to patient and procedural parameters and to changes in unit staffing or pro-cessing.The reservoir of bloodborne infection in the patient cohort was assessed,and recovery of viral nu-cleic acid from washes of patient-ready endoscopes used on patients shown to be infected with a blood-borne virus was attempted.METHODSPatient recruitmentThis study had ethical approval from the University of Sydney and Royal Prince Alfred Hospital(RPAH)eth-ics committees.Each patient attending the endoscopy unit,during the80-week study period,was invited to participate,unless they were too ill to give consent or were unable to communicate with the study team in English.Of the2120patients enrolled,100(4.7%) were a HCV positive,45(2.2%)were positive for he-patitis B surface antigen(HBsAg),and17(0.8%)were positive for HIV.Only62were highly infectious for hepatitis B virus(HBV)or HCV as determined by being PCR positive.14No patient was known to be suffering from infectious gastroenteritis.Patient demographics,procedural information(in-cluding type of endoscopy,biopsy retrieval,individual instrument used,attending medical and nursing per-sonnel,the cleaner of the endoscope),and diagnoses were collected.Thefirst500patients were telephoned 1month after their procedure and asked about any complications related to the procedure. Endoscope decontaminationEndoscopes were washed and decontaminated in accordance with guidelines produced by the Gastro-enterological Society of Australia.13Decontamination involved a3-step process consisting of precleaning while the endoscope was still attached to the light source,the exterior of the insertion tube was wiped, and detergent was aspirated through the suction chan-nel;manual cleaning of the endoscope by immersion in an enzymatic detergent(generally Medizyme,Whiteley Industries,Sydney)and the exterior and interior sur-faces cleaned using appropriate brushes;followed by automated disinfection in a Medivator(Egan,Minne-sota)using2%gluteraldehyde for20minutes,followed byflushing with sterilefiltered water and then isopro-panol prior to forced air drying.Wash sample collection and evaluation Wash samples were obtained immediately,from the internal surface of the endoscope,after comple-tion of the decontamination cycle byflushing the endoscope biopsy channels with20-mL sterile diethyl pyrocarbonate(DEPC)-treated,phosphate-buffered saline(PBS),which was collected into a sterile con-tainer.These samples were stored at4°C for up to4 hours before culture then archived at220°C.The risk of bacterial contamination in these2377samples was related to patient and staff procedural parameters. MicrobiologyCulture.Wash samples(1-mL aliquots)were cul-tured aerobically in nutrient broth(Oxoid,Melbourne, Australia)and anaerobically in cooked meat broth (Oxoid,Melbourne,Australia).Cultures were incubated at37°C for48hours and then checked for bacterial growth.Positive cultures were sent to the RPAH Micro-biology Department for typing to species level by routine methods.Nucleic acid detection.Washes(10.5mL)collected from endoscopes used on14and48HBV and HCV viremic patients,respectively,were ultracentrifuged at130,000g at4°C for17hours,and the pellet was re-suspended in200m L of TE(10mmol/LTris,0.1mmol/L EDT A).The viral nucleic acid was extracted by in-house guanidinium methods,based on that published by Casas et al15for HBV DNA and that by Chomczynski and Sacchis16for extraction of HCV RNA.Both methods were adapted by the addition of a phenol,chloroform, isoamyl alcohol step.Extracted wash samples were tested for viral nucleic acids by PCR of the surface gene17for HBV and reverse transcription(RT)-PCR of the5’UTR for HCV.18Similarly,washes from randomly selected washes negative for microbial growth from56gastroscopes and53colonoscopes were centrifuged at12,000rpm at4°C for1hour,and the pellet was resuspended in 200m L TE.The Gentra Puregene DNA extraction kit (GeneWorks,Adelaide,Australia)was used to extract samples for bacterial DNA and tested for the presence of coliform bacteria by PCR amplification of the LacZ gene19and for Escherichia coli and Shigella species by amplification of the UidA gene.19,20Wash samples from gastroscopes used on58pa-tients with confirmed Helicobacter pylori infections were centrifuged as above,and the bacterial DNA was extracted using DNAzol(Invitrogen,Carlsbad,CA)ac-cording to manufacturer’s recommendations.Samples were subjected to nested PCR amplification using Li et al’s primers EHC-U and EHC-L21in thefirst round, followed by a second round of PCR using ourprimers Bisset et al June20062755’-GAG ACT TTC CT A GAA GCG GTG TT and5’-AAA AGA ACC GAA CGC AAC AG,which augmented an186-bp se-quence of the urease C gene.The reaction mixture con-sisted of2nmol/L of each primer;1.25U T aq;2mmol/L MgCl2;and0.2mmol/L(each)dA TP,dCTP,dTTP,and dGTP in a1X reaction mix.Cycling conditions for both rounds of PCR were95°C for5minutes,55°C for1minute,and72°C for1.5minutes,followed by 39cycles of95°C for30seconds,55°C for1minute, and72°C for1.5minutes but with afinal extension time of10minutes.PCR products were analyzed by electrophoresis on a2%agarose gel.This PCR had a sensitivity of60organisms.StatisticsThe x2analysis or Fisher exact test was used as ap-propriate to test for differences between groups using the SigmaStat(Jandel Scientific,San Rafael,CA)statis-tical program.Linear regression was used to evaluate the correlation between contamination rates of patient-ready endoscopes and the number of times an endoscope was used and the number of procedures performed by endoscopy staff.In all statistical methods employed,statistical significance was assumed for a P value of,.05.For all tests,the confidence level was at95%,and the a value for test sensitivity was set at.05.RESULTSOverall,79%of endoscopy patients attending the unit during the study period participated in the study;8.5%of patients were not asked to join the study be-cause of clinical contraindications,poor communica-tion,or unavailability of a member of the study team. Reasons given by the12.5%of patients who refused to join the study included needle phobia,sick of tests, too old or sick,lives too far away,and concern about impending procedure,but over one third of patients gave no reason.Approximately equal numbers of men(1077)and women(1043)took part in the study.The median age of patients was52.3years(range,16-92years).Patient-ready endoscope wash resultsBacterial culture.Wash samples were obtained im-mediately following decontamination from1376upper procedures and987lower procedures.Wash samples from patient-ready gastroscopes and colonoscopes were equally likely to grow bacteria,with a1.9%and 1.8%contamination rate,respectively(see T able1). Generally,the numbers of bacteria cultured were low (,10organisms/mL).More than1organism was iso-lated from some endoscopes.However,in all samples that grew Bacillus species,only Bacillus species were found.Because glutaraldehyde is not expected to kill all spore-forming organisms,removing these isolates reduced the rate of patient bacteria persisting through the decontamination process to1.45%and1.5%for pa-tient-ready gastroscopes and colonoscopes,respectively.Organisms isolated from upper endoscopes(T able2) were Staphylococcus epidermidis,Staphylococcus sapro-phyticus,methicillin-resistant Staphylococcus aureus (MRSA),Pseudomonas aeruginosa,Bacillus species, Escherichia coli,Enterococcus species,diptheroids, Enterobacter aerogenes,and Serratia marcescens.The organisms isolated from lower endoscopes were Acinetobacter lwoffii,E coli,Enterococcus faecalis, Enterobacter cloacae,Staphylococcus epidermidis,he-molytic Streptococci,Bacillus species,Pseudomonas aeruginosa,Pseudomonasfluorescens,and coliforms.Nucleic acid testing.Bacterial DNA was detected by PCR in44of109(40%)of the culture negative washes collected from patient-ready endoscopes.However, H pylori DNA was not detected on any of the58wash samples obtained from gastroscopes used on con-firmed H pylori patients.There were14and48wash samples obtained from patient-ready endoscopes that had previously been used on HBV and HCV viremic patients,respectively. None of the endoscopes was positive for HBV DNA, and only1sample was positive for HCV RNA by PCR. This sample was from a gastroscope that had been used on a HCV-positive male patient who was not biop-sied and had no evidence of gastrointestinal disease. None of the500patients telephoned after their endos-copy had any complications that could be related to the procedure.Investigation of possible causes of decontamination breakdownPatient parameters.Endoscope decontamination failure following upper procedures was unrelated to patient gastrointestinal disease(P5.960),bloodborne viral status(P5.575),or sex(P5.814)or whether or not they were biopsied(P5.867)(see T able1).Similarly,decontamination failure of colonoscopes was unrelated to patient bloodborne viral status(P5 .613)or sex(P5.252)or whether or not the patient was biopsied or not(P5.594).In contrast,endoscopes used on those patients with evidence of lower gastro-intestinal disease were significantly more likely to remain contaminated through the decontamination process than colonoscopes used on patients with no evidence of gastrointestinal disease(P#.05)(see T able1).Instrument parameters.The overall contamination rate of patient-ready gastroscopes was1.9%,whereas276Vol.34No.5Bisset etalcontamination rates for individual gastroscopes varied between0%and3%.Linear regression analysis pro-duced a straight-line graph,indicating(R50.853, P,.001,F550.653)that the number of times an individual endoscope was contaminated was directly proportional to the number of occasions that the in-strument was used(see Fig1).Similarly,for colono-scopes,as the frequency of use increased,so did the number of times the individual endoscope was con-taminated(R50.945,P,.001,F5133.080). Endoscopy personnelThe number of procedures performed by individual endoscopists during the study period ranged from 1to763(T able3).The overall contamination rate of patient-ready endoscopes was1.86%,whereas con-tamination rates of patient-ready endoscopes follow-ing use by an endoscopist varied between0%and 8%.These differences were not statistically significant.Nurse assistants can have a major effect on decon-tamination efficacy if they fail to follow standard proto-cols.The study team evaluated cleaning protocols and found them to be followed rigidly.All the nurse assistants were fully trained,although some only worked on a casual basis and hence were not responsi-ble for cleaning many endoscopes.The number of en-doscopes cleaned by individual nurse assistants during the study period ranged from1to475.The differences in the percentage(0%-3.3%)of patient-ready endo-scopes remaining contaminated between nurses were not statistically significant(T able3). Decontamination procedureThe same decontamination protocol was followed throughout the study period,except for a1-week pe-riod during which,on the advice from the endoscope manufacturer,the endoscope buttons were disinfected, attached to the scope.During this period,there was a sharp but statistically nonsignificant increase in the number of contaminated patient-ready endoscopes (see T able4).Decontamination systemWaterfilters were changed when a loss of pressure occurred,on average,every15.2days or every thirdT able1.Contamination rates and percentage of patient-ready endoscopes related to previous patient use and demographic and procedural informationContaminationrateBiohazardous statusAbnormalreportNormalreport Carrier Noncarrier Male Female Biopsy No biopsyGastroscopes,n26/1376(1.9%)1/1220.8%25/12512.0%11/6931.6%15/6832.2%20/10501.9%6/3261.8%19/9732.0%7/4031.7% Colonoscopes,n18/987(1.8%)0/540%18/9331.9%6/4891.2%12/4982.4%9/4062.2%9/5811.5%14/5032.8%4/4840.8%T able2.Bacterial species isolated from patient-ready endoscopes*Number of isolations Bacteria isolated Gastroscopes Colonoscopes Staphlococcus epidermidis94 Staphlococcus saprophyticus1Staphlococcus aureus2yPseudomonas aeruginosa31 Pseudomonasfluorescens1 Bacillus species63 Escherichia coli23 Enterococcus species23 Enterobacter aerogenes1Enterobacter cloacae2 Micrococcus luteus1Serratia marcescens1Diptheroids1Acinetobacter lwoffii1 Hemolytic Streptococci2*Some endoscopes were contaminated with more than1organism(see text).y OneMRSA.Fig1.Linear regression analysis for gastroscopes, showing99%and95%confidence levels and prediction of contamination incidence numbers against total washes collected pergastroscope. Bisset et al June2006277working week.T o prevent dilution and hence loss of efficacy,the glutaraldehyde was replaced every 40cycles,which occurred,on average,every 12.1days or every second working week.There was no relation-ship between contamination of patient-ready endo-scopes and the life cycle of either the water filters or glutaraldehyde.DISCUSSIONThere has been considerable discussion regarding the clinical value of routine bacteriologic monitoring of endoscopes.Current Australian practice is for duo-denoscopes to be sampled monthly,colonoscopes and gastroscopes every 4months,and monthly sam-pling of the automated decontamination system.22In our study,we sampled immediately following each de-contamination cycle and inoculated 1mL wash sample into fluid cultures,and the methods were substantially more sensitive than the commonly recommendedtesting of small volumes of wash fluid on agar plates.17Even so,we found that,under conditions of careful adherence to working guidelines,there were very few instances in which we detected viable organisms in washes from endoscopes at the point of ing a contamination level of 2%and the recommended level of monitoring,it would take 1.8years to detect 1posi-tive wash sample in an endoscopy center possessing 10endoscopes.Even extrapolated to 20%contamination,there would still only be 1or 2positive samples occur-ring in a 4-month sampling period.These findings sug-gest that plate cultures performed on an infrequent schedule are unlikely to contribute to improved infec-tion control in endoscope units.Our samples were obtained from the endoscope’s internal surface immediately following decontamina-tion.Contamination of the samples by personnel is very unlikely because it is impossible to touch the area of the endoscope we sampled.All water to the automatic reprocessors was filter sterilized,thus pre-venting contamination of the clean endoscope with waterborne bacteria.The organisms isolated from both gastroscopes and colonoscopes are commonly isolated from the nasopharynx and/or the feces.In most instances,only a single organism was grown rather than a mixture,as expected from gastrointestinal contents.However,1gastroscope,which had been used on a patient who was currently infected with MRSA,the same strain of Staphylococcus aureus ,as well as Pseudo-monas aeruginosa and enterococci were recovered,and,in another wash,both Enterobacter and enterococci were isolated.Three colonoscopes also yielded 2or-ganisms (Enterobacter cloacae /Enterococcus species,Enterobacter cloacae/Pseudomonas aeruginosa ,andT able 3.Contamination rate of patient-ready endoscopes related to the endoscopist who performed the procedure and the nurse assistant who washed the instrument *Endoscopist Contaminationrate (%)T otal number of proceduresNurse assistantContamination rate(%)T otal number of washes18(1.7%)48310107203320931(4.8%)2138(3%)26540784013657(3.4%)2075032602866(2.2%)27978(4.9%)16475(2.5%)20380981(1%)10193(1.9%)16199(1.9%)4751012(1.6%)763106(1.9%)323112(1.4%)142119(3.3%)2701209612015131(1.3%)78130571407514062152(8%)251528*Endoscopists and nurse assistants numbers 1-14participated in procedures on a regular basis,whereas endoscopist or nurse assistant number 15represents a group of nonregular participants with only 1or 2procedures each.T able 4.Contamination rates of patient-readyendoscopes during a period of change in reprocessing protocol comparing disinfection of the endoscope buttons attached to or separated from the endoscopeWeek ContaminationNumber of scopesButton protocol 43179Separate 44064Separate 45582Attached to endoscope 46078Separate 47082Separate 4860Separate278Vol.34No.5Bisset etalE coli/hemolytic Streptococcus).The spectrum of orga-nisms recovered probably reflects both their ability to survive the decontamination procedure and selection by our culture methods.An important limitation of the latter was the time the washes were refrigerated under aerobic conditions before being cultured,which would have eliminated strict anaerobes.Nine of the 44positive washes grew Bacillus species,which is acceptable when instruments are disinfected and not sterilized.Removal of these washes reduced the rate of patient bacteria persisting through the decontami-nation process to1.5%or less.Biofilm has been shown to be present on channels of endoscopes sent for servicing,23and its practical effect on decontamination efficacy is unknown.Direct study of biofilm on endoscope channels was not prac-ticable in this clinical setting,so PCR detection of coli-form bacteria DNA was chosen as a surrogate marker for biofilm presence in culture-negative washes.A random selection of109culture-negative washes was centrifuged,extracted,and PCR amplified to observe for the presence of coliform bacteria.Coliform bacteria were chosen because they are likely to be derived from patients rather than the instrument room environment. Forty percent(22/56gastroscopes and21/53colono-scopes)were positive.PCR detection of nucleic acids does not necessarily indicate the presence of viable organisms,but organisms from biofilms may be very difficult to revive in planktonic culture,suggesting that further investigation of this issue is warranted. Only sterile water was used in the Medivator,with the employed waterfiltration system preventing orga-nisms from water pipe biofilms reaching the washing area and the automated reprocessor;therefore,bacte-rial DNA found in culture negative washes is likely to originate from the endoscope or the tubing of the auto-mated reprocessor.Overall,ourfindings suggest that carryover of orga-nisms on endoscopes after routine decontamination can be demonstrated at very low frequency and at low concentrations.There are unlikely to be serious consequences for individual patients from this carry-over of organisms from the normal gastrointestinal flora.Indeed,the500patients interviewed1month af-ter their procedures failed to recognize any complica-tions related to their procedures.We have also shown that many culture-negative washes contain bacterial nucleic acid,which we interpret as putative evidence of bacterial biofilm buildup on the surface of the endo-scope channels.The indications for endoscopy and the actual condi-tions diagnosed varied very widely in the study group. There was a slight increase in the likelihood of failure of the decontamination process for colonoscopes used on patients with an abnormal report.In contrast to epidemiologic evidence suggesting that biopsy during endoscopy was associated with an increased risk for HCV infection,24biopsy did not increase the rate of either viral nucleic acid or viable bacteria persisting through the decontamination cycle.Carryover of viral nucleic acid was found on only1of the62endoscopes that had been used to examine HBV and HCV viremic patients.This negative evidence is reassuring,and it should be noted that the positive PCR may well have been derived from inactivated rather than viable virus.25 Contamination of patient-ready endoscopes may also be attributed to inadequate maintenance of the de-contamination system.Adequate maintenance of the waterfiltration unit is necessary to prevent this.Reuse of glutaraldehyde results in its dilution and hence its activity with each cycle.The maintenance of thefilter system and changing of glutaraldehyde solutions were satisfactory throughout the study period.A change in procedure to decontamination of endoscope buttons attached to the endoscope resulted in a cluster of cul-ture-positive results.No clinically untoward conse-quences were observed,but thefinding shows the desirability of culture monitoring during changes in protocols to confirm satisfactory in use performance.Individual staff members carry an onerous responsi-bility for the maintenance of infection control in hos-pital practice.Endoscopy is particularly vulnerable because of the complexity of protocols for decon-tamination of expensive and fragile,heat-sensitive in-struments,which must be performed under time pressures in a ward rather than in centralized facilities. The study showed excellent adherence to protocols and a correspondingly high level of microbiologic safety in the unit.The authors thank the staff and patients of the Page5Endoscopy Suite,Royal Prince Alfred Hospital,Sydney,because,without their help and collaboration,this study could not have taken place and the Microbiology Department of the Royal Prince Alfred Hospital,Sydney,for identifying the bacterial species isolated. References1.Moayyedi P,Lynch D,Axon A.Pseudomonas and endoscopy.Endos-copy1994;26:554-8.2.Struelens MJ,Rost F,Deplano A,Maas A,Schwam V,Serruys E,et al.Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy:an outbreak investigation using DNA macrorestriction analysis.Am J Med1993;95:489-98.3.Spach DH,Silverstein FE,Stamm WE.T ransmission of infection bygastrointestinal endoscopy and bronchoscopy.Ann Intern Med1993;118:117-28.4.Nelson DB,Eisen G.Glutaraldehyde-based formulations.GastrointestEndosc2000;51:378.5.Bronowicki JP,Venard V,Botte´C,Monhoven N,Gastin I,Chone´L,et al.Patient-to-patient transmission of hepatitis C virus during colon-oscopy.N Engl J Med1997;337:237-40.6.Cryan EMJ,Falkiner FR,Mulvihill TE,Keane CT,Keeling PWN.Pseudo-monas aeruginosa cross-infection following endoscopic retrograde cholangiopancreatography.J Hosp Infect1984;5:371-6.Bisset et al June20062797.Lo Passo C,Pernice I,Celeste A,Perdichizzi G,T odaro-Luck F .T rans-mission of Trichosporon asahii esophagitis by a contaminated endo-scope.Mycoses 2001;44:13-21.8.Weber DJ,Rutala WA,DiMarino AJ Jr.The prevention of infection fol-lowing gastrointestinal endoscopy:the importance of prophylaxis and reprocessing.In:DiMarino AJ Jr,Benjamin SB,editors.Gastrointestinal diseases:an endoscopic approach.Thorofare,NJ:Slack Inc;2002.p.87-106.9.Noy MF ,Harrison L,Holmes GKT ,Cockel R.The significance of bacte-rial contamination of fiberoptic endoscopes.J Hosp Infect 1980;1:53-61.10.Coney S.Patients recalled after endoscopic ncet1999;354:578.11.Alvarado CJ,Reichelderfer M.APIC guidelines for infection preventionand control in flexible endoscopy.Am J Infect Control 2000;28:138-55.12.SGNA.Standards of infection control in reprocessing of flexiblegastrointestinal endoscopes.Gastroenterol Nurs 2000;23:172-87.13.Gastroenterological Society and Gastroenterological Nurses Societyof Australia.Guidelines:infection and endoscopy,3rd edition; .14.Vickery K,Bisset L,Selby W ,West R,Catterson D,Cossart YE.Bloodborne virus transmission during endoscopy–viral prevalence or decon-tamination breakdown?In:Jilbert AR,Grgacic EVL,Vickery K,Burrell C,Cossart YE,editors.Proceedings 11th International Symposium on Viral Hepatitis and Liver Disease.Melbourne:The Australian Centre for Hepatitis Virology;2004.p.344-6.15.Casas I,Powell PE,Klapper PE,Cleator GM.New method for the ex-traction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay.J Virol Methods 1995;53:25-36.16.Chromczynski P ,Sacchi N.Single-step method of RNA isolation byacid guanidinium thiocyanate-phenol-chloroform extraction.Anal Bio-chem 1987;162:156-9.17.Deva AK,Vickery K,Zou J,West RH,Selby W ,Benn RAV ,et al.Detection of persistent vegetative bacteria and amplified viral nucleic acid from in-use testing of gastrointestinal endoscopes.J Hosp Infect 1998;39:149-57.18.McGuinness P ,Bishop GA,Liem A,Wiley B,Parsons C,McCaughanGW .Detection of serum hepatitis C virus RNA in HCV antibody/seropositive volunteer blood donors.Hepatology 1993;18:485-90.19.Bej AK,DiCesare JL,Haff L,Atlas RM.Detection of Escherichia coli andShigella spp.in water by using the polymerase chain reaction and gene probes for uid .Appl Environ Microbiol 1991;57:1013-7.20.Fricker EJ,Fricker CR.Application of the polymerase chain reaction tothe identification of Escherichia coli and coliforms in water.Lett App Microbiol 1994;19:44-6.21.Li C,Ha T ,Ferguson D,Chi DS,Zhao R,Patel NR,et al.A newlydeveloped PCR assay of H.pylori in gastric biopsy,saliva,and feces:evidence of high prevalence of H.pylori in saliva supports oral trans-mission.Dig Dis Sci 1996;41:2142-9.22.Anonymous.Cleaning and disinfection of equipment for gastrointesti-nal endoscopy:report of a working party of the British Society of Gastroenterology.Endoscopy committee.Gut 1998;42:585-93.23.Pajkos A,Vickery K,Cossart YE.Is biofilm accumulation on endo-scope tubing a contributer to failure of cleaning and decontamination?J Hosp Infect 2004;58:224-9.24.Andrieu J,Barny S,Colardelle P ,Maisonneuve P ,Giraud V ,Robin E,et al.Prevalance and risk factors for hepatitis C infection in a hospital-ised population in gastroenterology:role of perendoscopic biopsies.Gastroenterol Clin Biol 1995;19:340-5.25.Deva AK,Vickery K,Zou J,West RH,Harris JP ,Cossart YE.Establish-ment of an in-use testing method for evaluating disinfection of surgical instruments utilising the duck hepatitis B model.J Hosp Infect 1996;33:119-30.280Vol.34No.5Bisset etal。

相关文档
最新文档